Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
81 hedge funds and large institutions have $7.96M invested in Ampio Pharmaceuticals Inc. in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 16 closing their positions.
976% more call options, than puts
Call options by funds: $226K | Put options by funds: $21K
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
4% less funds holding
Funds holding: 84 → 81 (-3)
28% less capital invested
Capital invested by funds: $11M → $7.96M (-$3.03M)
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.78M |
| 2 |
Millennium Management
New York
|
+$1M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$280K |
| 4 |
Goldman Sachs
New York
|
+$235K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$233K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$547K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$314K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$195K |
| 5 |
MA
Montag & Associates
Atlanta,
Georgia
|
-$129K |
AMPE Hedge Fund Activity: Q2 2019 in Review
81 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2019, worth a combined $7.96M — down 28% from $11M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of AMPE and 15 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 13 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $2.78M. The largest seller was BlackRock, cutting an estimated $2.5M.
- 81 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2019, down from 84 in Q1 2019.
- Funds reported $7.96M of Ampio Pharmaceuticals Inc. stock for Q2 2019, down 28% quarter-over-quarter.
- 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2019 and 16 closed out, a net change of -1 holder.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2019 was Sabby Management, an estimated $2.78M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2019 was BlackRock, an estimated $2.5M sold.
Based on aggregated 13F filings for Q2 2019.